Mayne Pharma | MYX - Aset Lancar

Harga Saham

2.62

Perubahan Harian

0.05 1.95%

Bulanan

11.49%

Tahunan

-62.57%

Q2 Perkiraan

2.52

Keuangan

AUD

AUD 1.14B

AUD 110.07M

Biaya Penjualan

AUD 43.74M

AUD 460.59M

Kewajiban Lancar

AUD 313.94M

AUD 38.82M

AUD -16.2M

AUD 20.9M

450

Eps Laba Per Saham

AUD -0.15

Modal Dan Cadangan

AUD 454.19M

Laba Kotor Pada Penjualan

AUD 86.13M

Beban Bunga Utang

AUD 1.2M

AUD 2.66M

Kapitalisasi Pasar

AUD 218.64M

Batas Pemasukan

AUD -103.68M

Biaya Operasional

AUD 103.54M

Laba Operasional

AUD -3.3M

Modal Saham Biasa

AUD 81.25M

Laba Sebelum Pajak

AUD -14.7M

Pendapatan Penjualan

AUD 212.07M

Beban Penjualan Dan Administrasi

AUD 54.8M

AUD 74.63M

Kreditur Perdagangan

AUD 30.25M

Debitur Perdagangan

AUD 193.22M

	Aset Lancar	Perubahan		Tanggal
Ansell	USD 1.11B		5.2M	2025-12
Avita Medical	AUD 35.49M		760K	2025-12
Cochlear	AUD 1.37B		43.9M	2025-12
CSL	USD 11.85B		1000K	2025-12
Healius	AUD 1.04B		737.9M	2024-12
Integral Diagnostics	AUD 74.82M		9.15M	2024-06
Medical Developments International	AUD 33.75M		1.79M	2025-12
Nanosonics	AUD 234.13M		8.81M	2025-12
Polynovo	AUD 69.23M		7.87M	2025-12
Ramsay Health Care	AUD 3.56B		480.3M	2025-12
ResMed	USD 3.82B		193.06M	2025-12
Sigma Healthcare	AUD 2.91B		2B	2025-12
Sonic Healthcare	AUD 2.3B		52.76M	2024-12
Telix Pharmaceuticals	AUD 330.28M		67.73M	2025-12